0001104659-11-065789.txt : 20111122 0001104659-11-065789.hdr.sgml : 20111122 20111122160730 ACCESSION NUMBER: 0001104659-11-065789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111122 FILED AS OF DATE: 20111122 DATE AS OF CHANGE: 20111122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 111222035 BUSINESS ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND STATE: V8 ZIP: CH 4056 MAIL ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND ZIP: CH 4056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDENIX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001093649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450478605 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-9800 MAIL ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: NOVIRIO PHARMACEUTICALS LTD DATE OF NAME CHANGE: 19990820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS PHARMA AG CENTRAL INDEX KEY: 0001030617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 111222034 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 BUSINESS PHONE: 212-830-2474 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 FORMER NAME: FORMER CONFORMED NAME: NOVARTIS INC DATE OF NAME CHANGE: 19970114 4 1 a4.xml 4 X0304 4 2011-11-22 0 0001093649 IDENIX PHARMACEUTICALS INC IDIX 0001114448 NOVARTIS AG LICHSTRASSE 35 BASEL V8 CH4002 SWITZERLAND 0 0 0 1 Indirect 10% Owner 0001030617 NOVARTIS PHARMA AG LICHSTRASSE 35 BASEL V8 CH4002 SWITZERLAND 0 0 1 0 Common Stock 2011-11-22 4 P 0 11236 2.41 A 33196427 I See footnote Common Stock 2011-11-22 4 P 0 6476 2.95 A 33202903 I See footnote Common Stock 2011-11-22 4 P 0 1146 3.17 A 33204049 I See footnote Common Stock 2011-11-22 4 P 0 140 3.79 A 33204189 I See footnote Common Stock 2011-11-22 4 P 0 20228 4.70 A 33224477 I See footnote Common Stock 2011-11-22 4 P 0 2107 5.11 A 33226584 I See footnote Common Stock 2011-11-22 4 P 0 9197 5.46 A 33235781 I See footnote These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment. /s/ Felix Eichhorn Authorized Signatory 2011-11-22 /s/ Matt Owens Authorized Signatory 2011-11-22